These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36442077)

  • 1. Iron Oxide Nanoparticles Decorated with Functional Peptides for a Targeted siRNA Delivery to Glioma Cells.
    Chung S; Sugimoto Y; Huang J; Zhang M
    ACS Appl Mater Interfaces; 2023 Jan; 15(1):106-119. PubMed ID: 36442077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nanoprodrug of polytemozolomide combines with MGMT siRNA to enhance the effect of temozolomide in glioma.
    Xu H; Zhang Y; Li L; Ren Y; Qian F; Wang L; Ma H; Quan A; Liu H; Yu R
    Drug Deliv; 2023 Dec; 30(1):1-13. PubMed ID: 36579448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination treatment with theranostic nanoparticles for glioblastoma sensitization to TMZ.
    Yoo B; Ifediba MA; Ghosh S; Medarova Z; Moore A
    Mol Imaging Biol; 2014 Oct; 16(5):680-9. PubMed ID: 24696184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The L84F polymorphic variant of human O6-methylguanine-DNA methyltransferase alters stability in U87MG glioma cells but not temozolomide sensitivity.
    Remington M; Chtchetinin J; Ancheta K; Nghiemphu PL; Cloughesy T; Lai A
    Neuro Oncol; 2009 Feb; 11(1):22-32. PubMed ID: 18812520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of aberrant p53 function on temozolomide sensitivity of glioma cell lines and brain tumor initiating cells from glioblastoma.
    Blough MD; Beauchamp DC; Westgate MR; Kelly JJ; Cairncross JG
    J Neurooncol; 2011 Mar; 102(1):1-7. PubMed ID: 20593219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O6-methylguanine DNA methyltransferase as a promising target for the treatment of temozolomide-resistant gliomas.
    Fan CH; Liu WL; Cao H; Wen C; Chen L; Jiang G
    Cell Death Dis; 2013 Oct; 4(10):e876. PubMed ID: 24157870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Class I HDAC overexpression promotes temozolomide resistance in glioma cells by regulating RAD18 expression.
    Hanisch D; Krumm A; Diehl T; Stork CM; Dejung M; Butter F; Kim E; Brenner W; Fritz G; Hofmann TG; Roos WP
    Cell Death Dis; 2022 Apr; 13(4):293. PubMed ID: 35365623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma.
    Chen Z; Wei X; Shen L; Zhu H; Zheng X
    Cancer Sci; 2019 Jan; 110(1):389-400. PubMed ID: 30431207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine.
    Roos WP; Batista LF; Naumann SC; Wick W; Weller M; Menck CF; Kaina B
    Oncogene; 2007 Jan; 26(2):186-97. PubMed ID: 16819506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells.
    Hermisson M; Klumpp A; Wick W; Wischhusen J; Nagel G; Roos W; Kaina B; Weller M
    J Neurochem; 2006 Feb; 96(3):766-76. PubMed ID: 16405512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoresistance to temozolomide in human glioma cell line U251 is associated with increased activity of O6-methylguanine-DNA methyltransferase and can be overcome by metronomic temozolomide regimen.
    Pan Q; Yang XJ; Wang HM; Dong XT; Wang W; Li Y; Li JM
    Cell Biochem Biophys; 2012 Jan; 62(1):185-91. PubMed ID: 21892781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies to improve the killing of tumors using temozolomide: targeting the DNA repair protein MGMT.
    Jiang G; Li LT; Xin Y; Zhang L; Liu YQ; Zheng JN
    Curr Med Chem; 2012; 19(23):3886-92. PubMed ID: 22788764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of O6-methylguanine-DNA methyltransferase promoter methylation in chemotherapy for glioma].
    Zheng CQ; Ji SP; Gong F; Li AM; Tai JL; Zhang YP
    Ai Zheng; 2009 Jun; 28(6):575-80. PubMed ID: 19635193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations of MGMT genetic polymorphisms with temozolomide resistance and prognosis of patients with malignant gliomas: a population-based study in China.
    Wang HW; Xu ZK; Song Y; Liu YG
    Cancer Gene Ther; 2017 May; 24(5):215-220. PubMed ID: 28409559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional control of O
    Happold C; Stojcheva N; Silginer M; Weiss T; Roth P; Reifenberger G; Weller M
    J Neurochem; 2018 Mar; 144(6):780-790. PubMed ID: 29480969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New (alternative) temozolomide regimens for the treatment of glioma.
    Wick W; Platten M; Weller M
    Neuro Oncol; 2009 Feb; 11(1):69-79. PubMed ID: 18772354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing a clinically relevant radiosensitizer for temozolomide-resistant gliomas.
    Minea RO; Duc TC; Swenson SD; Cho HY; Huang M; Hartman H; Hofman FM; Schönthal AH; Chen TC
    PLoS One; 2020; 15(9):e0238238. PubMed ID: 32881880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of N-methylpurine DNA glycosylase in resistance to temozolomide in patient-derived glioma cells.
    Serrano-Heras G; Castro-Robles B; Romero-Sánchez CM; Carrión B; Barbella-Aponte R; Sandoval H; Segura T
    Sci Rep; 2020 Dec; 10(1):22185. PubMed ID: 33335215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of DNA-repair genes Ercc1 and Mgmt enhances temozolomide efficacy in gliomas treatment: a pre-clinical study.
    Boccard SG; Marand SV; Geraci S; Pycroft L; Berger FR; Pelletier LA
    Oncotarget; 2015 Oct; 6(30):29456-68. PubMed ID: 26336131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant TP53 enhances the resistance of glioblastoma cells to temozolomide by up-regulating O(6)-methylguanine DNA-methyltransferase.
    Wang X; Chen JX; Liu YH; You C; Mao Q
    Neurol Sci; 2013 Aug; 34(8):1421-8. PubMed ID: 23224642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.